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Background: Experimental screening of chemical compounds for biological activity is a time consuming and
expensive practice. In silico predictive models permit inexpensive, rapid “virtual screening” to prioritize selection of
compounds for experimental testing. Both experimental and in silico screening can be used to test compounds for
desirable or undesirable properties. Prior work on prediction of mutagenicity has primarily involved identification of
toxicophores rather than whole-molecule predictive models. In this work, we examined a range of in silico
predictive classification models for prediction of mutagenic properties of compounds, including methods such as
J48 and SMO which have not previously been widely applied in cheminformatics.
Results: The Bursi mutagenicity data set containing 4337 compounds (Set 1) and a Benchmark data set of 6512
compounds (Set 2) were taken as input data set in this work. A third data set (Set 3) was prepared by joining up
the previous two sets. Classification algorithms including Naïve Bayes, Random Forest, J48 and SMO with 10 fold
cross-validation and default parameters were used for model generation on these data sets. Models built using the
combined performed better than those developed from the Benchmark data set. Significantly, Random Forest
outperformed other classifiers for all the data sets, especially for Set 3 with 89.27% accuracy, 89% precision and ROC
of 95.3%. To validate the developed models two external data sets, AID1189 and AID1194, with mutagenicity data
were tested showing 62% accuracy with 67% precision and 65% ROC area and 91% accuracy, 91% precision with
96.3% ROC area respectively. A Random Forest model was used on approved drugs from DrugBank and
metabolites from the Zinc Database with True Positives rate almost 85% showing the robustness of the model.
Conclusion: We have created a new mutagenicity benchmark data set with around 8,000 compounds. Our work
shows that highly accurate predictive mutagenicity models can be built using machine learning methods based on
chemical descriptors and trained using this set, and these models provide a complement to toxicophores based
methods. Further, our work supports other recent literature in showing that Random Forest models generally
outperform other comparable machine learning methods for this kind of application.
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In the past two decades high throughput screening (HTS)
has provided a large amount of experimental data on com-
pound biological activities. Data mining and machine learn-
ing methods provide an in silico counterpart building
predictive models based on chemical structure features and
other properties, and training sets of known bioactivities.
Despite these capabilities quantitative methods do not tend* Correspondence: abseal@indiana.edu
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reproduction in any medium, provided the orto model the biochemical and physiological process well.
Recent developments in machine learning have focused on
the exploration of large data sets with non–congeneric
molecules. The applicability of Quantitative Structure Ac-
tivity Relationship (QSAR) studies to predict toxicity is very
limited. The rationale behind the use of machine learning is
to discover patterns and signatures in data sets from high
throughput in-vitro assays. Nonetheless, the development
of in-silico models as alternative approaches to mutageni-
city assessment of chemicals without animal testing is con-
stantly increasing and has attracted researchers in the field
of Quantitative Biological Activity Relationship (QBAR) [1]
and even toxicology.Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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genotoxicity. Experimentally, mutagenicity is assessed
by Ames test performed on Salmonella typhimurium
bacterial strains where each bacterial strain is sensi-
tive to specific chemical mutagen [2]. It has been
found that the predictive power of positive Ames test
for rodent carcinogenicity is high, ranging from 77%
to 90% [3]. Kazius et al. [4] assembled a data set of
4337 compounds and derived 29 toxicophores with
an error rate of 18% in training set and 15% in a val-
idation test set. Helma et al. [5] reported MOLFEA
algorithm for generation of descriptors based on mo-
lecular fragments for non-congeneric compounds and
compared various machine learning algorithms with
its data set of 684 compounds derived from Carcino-
genic Potency Database (CPDB: http://potency.
berkeley.edu/). The data set gave an accuracy of 78%
with 10 folds of cross validation. Hansen et al. [6]
reported a unique new public Ames Mutagenicity
data set with 6500 compounds and compared results
with commercial and non-commercial tools. Zhang
and Sousa [7] also reported the use of MOLMAP
descriptors for bond properties which were used for
training of Random Forest classifier. Error percen-
tages, as low as 15% - 16% were achieved with an
external validation set of 472 compounds against a
training set of 4083 structures. Up to 91% sensitivity
and 93% specificity were obtained from the test sets.
Feng et al. [8] used four data sets NCI, Mut, Yeast
and Tox and generated four different types of
descriptors. Using statistical methods, models were
built to link chemical descriptors to the biological
activity. King et al. [9] reported different methods for
establishing structure activity relationships (SARs).
They represented chemical structures by atoms and
bond connectivities in combination with inductive logic
programming algorithm Progol. They tested 230 com-
pounds which were divided in two sets of 188 com-
pounds and 42 compounds. For 42 compounds Progol
formed a SAR better than linear regression and back
propagation. Judson et al. [10] used different classifiers
to predict the accuracy of the model of complex chem-
ical toxicology data sets. Neural networks and Support
Vector Machines (SVM) were at the top of the list of
classifiers, predicting with 96% and 99% specificity, re-
spectively. They also mentioned that irrelevant features
decreased the accuracy rate, with linear discriminant
analysis suffering the maximum degradation. Ferarri
and Gini [11] proposed the idea of a trained QSAR
classifier supervised by a SAR layer that incorporates
coded human knowledge. The model is implemented in
the CAESAR project (http://www.caesar-project.eu)
[12] where initially a classifier is trained on more than
four thousand molecules based on Bursi data set byusing molecular descriptors, then in the next step the
relative knowledge to complement its practice is
extracted from a collection of well-known structural
alerts. Votano et al. [13] reported the application of
three QSAR methods using artificial neural networks,
k-nearest neighbors, and decision forest, to a data set of
3363 diverse compounds. They used molecular con-
nectivity indices, electrotopological state indices, and
binary indicators to obtain an accuracy of 82%.
Unlike many bioactivities, mutagenicity can be linked
to very specific chemical structure fragments and func-
tional groups, usually referred to as toxicophores, which
interfere with DNA [14-16]. These include aromatic
amines, hydroxyl amines, nitroso compounds, epoxides,
thiols, nitrogen mustards, aziridines, aromatic azo’s, pro-
piolactones, aliphatic halides, thiophenes, heteroatom
derivatives, polycylic planar compounds, hydrazine,
hydrazide and hydroxylamine. It has also been found
that detoxifying structures such as the CF3, SO2NH,
SO2OH and aryl sulphonyl derivates render mutagenic
compounds non-mutagenic [17].
In this paper, firstly, we have applied four classification
algorithms - Naïve Bayes, J48, Random Forest and Se-
quential Minimal Optimizer (SMO) - to model the
mutagenicity data of compounds. In particular, we were
interested in discovering whether such “whole molecule”
algorithms are appropriate for mutagenicity prediction,
or whether this is better done using simple alerts based
on toxicophores. We were also interested in whether we
would replicate previous work indicating that Random
Forest is a better classifier than other Base and Ensemble
classifiers [18]. We tested the model with validation sets
(PubChem data sets AID1189 and AID1194, DrugBank
[19] approved, and withdrawn drugs and Zinc metabo-
lites data (zinc.docking.org/browse/subsets/special.php)
[20] all of which indicate that the Random Forest model
performs well.
Methods
Data sets
This work included 3 training data sets: Set 1 (Bursi
mutagenicity data set) having a total of 4337 com-
pounds, Set 2 (Benchmark data set) with 6512 com-
pounds and Set 3 which was a combination of Set 1 and
Set 2 containing 8208 compounds after removing the
duplicate structures based on the canonical smiles of
the Set 1 and Set 2 using Pipeline Pilot [21]. The data
sets were divided into training (80%) and testing (20%).
The datasets are given in the Additional file 1 and Add-
itional file 2. Table 1 shows the distribution of com-
pounds on the training and test sets of the three sets
(Set 1, Set 2 and Set 3). For using the datasets in Weka
we performed the remove useless feature option which
removes the unnecessary variables from the data. We
Table 1 Distribution of different data sets and it
compounds (mutagens and non-mutagens) in test and
train sets
Data sets Training Training Test mutagen Test non Minority %
Mutagen Non mutagen Mutagen
Set 1 1916 1554 485 382 55.38
Set 2 2803 2407 700 602 53.79
Set 3 3639 2871 910 788 55.40
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sification. For set 1 “remove useless” operation in Weka,
of the initial 179 descriptors, 151 descriptors which con-
tained 24 weighted burden number descriptors, 8 prop-
erties descriptor and 120 pharmacophore fingerprints
were obtained. For set2 and 3 the remove useless oper-
ation resulted in 154 descriptors (of the initial 179
descriptors) which contained 24 weighted burden num-
ber descriptors, 8 properties descriptors and 123
pharmacophore fingerprints.
For validation of the generated model, external test sets
were used. External data sets, AID1189 and AID1194, were
taken from EPA DSSTOX data set in the CPDB [22].
AID1189 contained 1477 compounds with 788 mutagens
and 689 non-mutagens and AID1194 contained 832 com-
pounds with 396 mutagens and 436 non-mutagens. The
toxicity models were tested against the 1410 approved
drugs and 66 withdrawn drugs from the DrugBank data-
base and as well as with the 22080 metabolite data which
were taken from the recently published ZINC Data sets.
The metabolites may be toxic or non-toxic the idea here is
to check whether the compounds formed after metabolism
has some mutagenicity or not using our predictive models.
Chemical descriptors
For each data set, descriptors were calculated by PowerMV
[23]. PowerMV calculates a total of 6122 descriptors classi-
fied as 546 atom pair descriptors, 4662 Carhart descriptors,
735 fragment pair descriptors, 147 pharmacophore finger-
prints, 24 Weighted Burden Number descriptor and 8
properties descriptors. Among those we used:
Property descriptors including XlogP (a measure of the
propensity of a molecule to partition into water or oil),
polar surface area (PSA), number of rotatable bonds,
H-bond donors, H-bond acceptors, molecular weight,
blood–brain indicator (0 indicating a compound does
not pass the BBB, and 1 indicating that a compound
passes the BBB) and bad group indicator (the molecule
contains a chemically reactive or toxic group).
Pharmacophore Fingerprint descriptors based on bioi-
sosteric principles. They are divided in to six classes to-
taling to 147 descriptors.
Weighted Burden number descriptors, a set of continu-
ous descriptors and are also a variation of the Burdennumber [24]. One of the three properties, namely, electro-
negativity, Gasteiger partial charge or atomic lipophilicity
and XLogP is placed on the diagonal of the Burden con-
nectivity matrix. The off-diagonal elements are weighted
by one of the following values: 2.5, 5.0, 7.5 or 10.0. Then
the largest and the smallest eigenvalues are used as
descriptors.
Machine learning classifiers
Machine learning has been widely used in classifying mole-
cules as active or inactive, mutagen or non-mutagen against
a protein target [25]. In this work we used Weka [26] open
source software which is a collection of different classifiers
for data mining and machine learning. It is licensed under
GNU GPL. It includes tools for data pre-processing, classi-
fication, regression, clustering, association rules, and
visualization. Of the many data mining approaches that
have been explored, four have evolved to largely
dominate other classificationmethods at present. These are
a) Bayesian methods [27] b) Support Vector Machines [28]
c)Decisiontrees[29]andd)RandomForest[30,31].
Workflow
The data sets were downloaded in SD File format. The
PowerMV descriptor calculation tool was used to generate
chemical descriptors. A total of 179 descriptors were gen-
erated for all the three data sets used. Bioassay data was
appended as an outcome column to each of the data sets
in the comma separated values (CSV) file format. The
compounds were labeled mutagens and non-mutagens
based on the respective bioassay data. After merging of
Set1 and Set 2 compounds, the duplicate compounds are
removed from the data and it resulted in 8292 compounds
representing Set 3 data set. Useless descriptors were
removed among the 179 descriptors which resulted in 155
descriptors for Set 2 and Set 3 and 152 descriptors for Set
1. Each data set was trained with 10 fold cross validation
with default parameters for all the four classifiers men-
tioned earlier. The models generated were tested with
remaining 20% test data and also validated using external
data sets from PubChem AID1189 and AID1194, Drug-
Bank drugs and Zinc metabolites data. Additional file 3
contains the csv formatted file of descriptors for exter-
nal datasets. Using the knowledge flow provided by
Weka, a workflow represented in Figure 1 was prepared
which loads the data sets, applies the classifiers to gen-
erate the models which are tested using the test
compounds.
Results
The results are discussed for each of the data sets for
which the models were developed using the four classi-
fiers. The Random Forest was parameterized with 100
trees because we did not find much difference in the out
Table 2 Result table for Set 1 with four classifier algorithms Naïve Bayes, Random Forest, J48 and SMO
Classifiers TP% FP% TN% FN% Accuracy% Average Average Average
Precision% Recall% ROC
Naïve Bayes 69.9 42.1 57.9 30.1 64.59 67.8 69.89 71.90%
Random Forest 83.7 21.7 78.3 16.3 79.81 79.5 78.3 89.2%
J48 79 27 73 21 76.35 78.8 78.96 77.20%
SMO 74 34.6 65.4 26 70.24 73.1 74.02 77.10%
Random Forest showed the Best accuracy with 79.81% and ROC Area of 89.2%. It also has high True Positive (TP) rate with low False Positive (FP) rate.
Figure 1 The diagram above represents the knowledge workflow model of Weka environment software.
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than 0.5%).
Set 1: The results given in Table 2 show that Random
Forest outperformed the other classifiers. For Set 1 the
Random Forest classifier classified internal 20% test data
with 79.81% accuracy, 79.5% average precision and
89.2% AUC ROC which is the best model for the Set 1.
For the external set, AID1189, it classified with 64.65%
accuracy, 66.4% Average precision and 67.3% AUC ROCTable 3 Result table for AID1189 taken as test set for the
models prepared by different sets i.e. Set 1, Set 2 and Set 3
Classifiers Data set Accuracy% Precision % Recall% ROC
Naïve Bayes Set 1 49.08 53.3 36.80 50.30%
Set 2 49.28 53.7 36.29 50.60%
Set 3 49.01 51.5 49 55.5%
Random Forest Set 1 64.65 66.4 64.7 67.3%
Set 2 61.61 66.6 56.21 64.50%
Set 3 62.89 64 62.9 65.60%
J48 Set 1 63.16 68.6 57.10 64.60%
Set 2 60.39 66 53.04 62.50%
Set 3 61.27 62.1 62.3 60.8%
SMO Set 1 50.57 55.3 38.57 55.90%
Set 2 57.14 63.2 46.95 57.90%
Set 3 56.12 57 56.1 61.2%
It was found that AID1194 classified better on Set 3 with above 90% accuracy.as shown in Table 3. For AID1194 it predicted 84.85%
accuracy, 84.9% Average precision and 93.1% AUC ROC
as shown in Table 4. Figure 2 depicts the number of
True Positive (TP), False Positive (FP), True Negative
(TN), and False Negative (FN) compounds predicted in
Set 1.
Set 2: The results provided in Table 5 portray the pre-
dictive power of the Random Forest algorithm. Here it
was observed that for Set 2 the Random Forest classifiedTable 4 Result table for AID1194 taken as validation set
for the models generated on different sets i.e. Set 1, Set
2 and Set 3
Classifiers Data set Accuracy% Precision % Recall% ROC
Naïve Bayes Set 1 55.76 54.3 42.78 57.50%
Set 2 55.88 54.6 42.27 58.00%
Set 3 61.05 63.2 61.1 66.8%
Random Forest Set 1 84.85 86.3 81 93.1%
Set 2 87.86 87.7 86.58 94.30%
Set 3 90.14 90.1 90.1 96.8%
J48 Set 1 80.88 79.0 80.50 84.20%
Set 2 84.37 85.7 80.50 86.20%
Set 3 87.01 87 87 88.7%
SMO Set 1 62.01 62.6 49.62 67.60%
Set 2 69.23 71.8 57.97 68.70%
Set 3 56.12 57 56.1 61.2%
It was found that AID1194 classified better on Set 3 with above 90% accuracy.
Table 5 Result table for Set 2 with four classifier algorithms Naïve Bayes, Random Forest, J48, and SMO
Classifiers TP% FP% TN% FN% Accuracy% Precision % Recall% ROC
Naïve Bayes 70.9 45.5 54.5 29.1 63.28 64.4 70.85 69.60%
Random Forest 80.6 22.4 17.6 19.4 79.18 79.2 79.2 87.4%
J48 74.3 27.1 72.9 25.7 73.65 74.0 74.28 77%
SMO 69.9 37.5 62.5 30.1 66.43 68.4 69.85 78.10%
Random Forest showed the Best accuracy 85.15% with ROC Area 92.4%. It also has high True Positive (TP) rate with low False Positive.
Figure 2 The graph represents number of Set 1 compounds classified by TP, FN, FP and TN by Naive Bayes, Random Forest, J48 and
SMO classifiers.
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precision and 85% AUC ROC. J48 also performed well
with 73.6% accuracy but was not better than Random
Forest. With external test set AID1189 it classified with
61.6% accuracy, 66.6% precision and 64.5% ROC area as
given in Table 3. With AID1194 it classified 87.86% ac-
curacy, 87.7% precision and 94.3% AUC ROC as given in
Table 4. Figure 3 depicts the number of True PositiveFigure 3 The graph represents number of Set 3 compounds classified
SMO classifiers.(TP), False Positive (FP), True Negative (TN), and False
Negative (FN) compounds predicted in Set 2.
Set 3: 154 descriptors were taken from initial 179
descriptors ,which contained 24 272 weighted burden
number descriptors, 8 properties 273 descriptors and
124 pharmacophore fingerprints. The results are given
in Table 6 classifiers. After merging compounds from
the two sets it was observed that Random Forest wasby TP, FN, FP and TN by Naive Bayes, Random Forest, J48 and
Table 6 Result table for Set 3 with four classifier algorithms Naïve Bayes, Random Forest, J48, and SMO
Classifiers TP% FP% TN% FN% Accuracy% Precision % Recall% ROC
Naïve Bayes 66.3 28.2 71.8 33.7 68.84 69.3 68.8 75.8%
Random Forest 86.7 16.6 83.4 13.3 85.15 85.2 85.2 92.4%
J48 83.1 26 74 16.9 78.85 78.9 78.9 80.7%
SMO 76.6 34.4 65.6 29.3 71.4 71.5 71.5 78.5%
Random Forest showed the Best accuracy 85.15% with ROC Area 92.4%. It also has high True Positive (TP) rate with low False Positive.
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gave more accurate results than for the other two set
(Tables 3 and 4). For the internal 20% test set it gave an
accuracy of almost 90% and AUC ROC of 95.3%. For
AID1194 it showed an accuracy of 91.9% with ROC area
of 96.3%. The other classifier J48 gave an accuracy of
87%. Figure 4 mentions the number of True Positive
(TP), False Positive (FP), True Negative (TN), and False
Negative (FN) compounds predicted in Set 3.
For each of the data sets modeled with Random Forest
performance was much better than the other classifiers.
The Random Forest model performs an implicit feature
selection, using a small subset of "strong variables" for
the classification only, leading to its superior perform-
ance on high dimensional data. The outcome of this im-
plicit feature selection of the Random Forest can be
visualized by the "Gini importance". In the Figure 5, im-
portant variables used in Random forest model gener-
ation are represented. We also used the important
variables based on Gini Importance i.e. 30 listed in the
diagram to model our data sets. For all the test sets of
the three sets the accuracy was in range of 79% to 84%.
The variable selection using Gini importance resulted in
a decrease of accuracy rate to 1% to 1.5%. Descriptor
optimization is an important step while making learning
models. Descriptors are often selected based on the cor-
relation methodology [32] for example in Weka, a cfsFigure 4 The graph represents number of Set 3 compounds classified
SMO classifiers.subset Eval attribute evaluator is present which selects
the most uncorrelated descriptors for model generation.
The Gini importance showed in the Figure 5 is another
approach of variable selection which is based on in-
equality among values of a frequency distribution on
each split of the tree [33]. It is defined as a ratio with
values between 0 and 1: the numerator is the area be-
tween the Lorenz curve of the distribution and the uni-
form distribution line; the denominator is the area under
the uniform distribution line.
We use the models to test the 1410 approved drugs
compounds and 66 withdrawn drugs and also 22080
metabolites in the ZINC database. It was assumed that
the approved drug compounds would not show muta-
genicity and hence, were labeled as non-mutagens. The
withdrawn compounds show various pharmacological
side effects and among them mutagenicity could also be
an important side effect. So, the withdrawn compounds
were labeled as mutagens. Among the metabolites 9523
compounds were labeled as mutagens and remaining as
non-mutagens arbitrarily. We tested the compounds on
the three sets with Random Forest of 100 trees. The
Table 7 displays the tested compounds results.
Each model was tested with the drug data and the
metabolites data. It was found that every model pre-
dicted the drug data with almost the same specificity i.e.
the true negatives which were labeled as non- mutagen.by TP, FN, FP and TN by Naive Bayes, Random Forest, J48 and
Figure 5 Set 3 Variable Importance Graph.
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cificity. To improve the model of prediction of true
negatives we also implemented the classification with
cost matrix in Weka and tested our data sets. We set the
cost of false positive to 2.5 for misclassifying every non-
mutagenic compound. Every data set was classified with
more than 90% as true negative. The models predicted
the withdrawn drugs data with low sensitivity and it
predicted most of the compounds as false positives
(non-mutagen). The compounds from Zinc metabolites
database show very low mutagenic effects to the living
systems and after testing with each model it was observed
that Set 3 gave the best classification of the compounds.
From 9523 mutagen compounds labeled arbitrarily, it pre-
dicted 8037 compounds as false negatives (mutagensTable 7 The drug and the metabolites data tested with Set 1,
Datasets True Positives
Set1 (Drug Data) 16.7
Set1(Metabolites) 17.2
Set1(Cost sensitive classification of Drug data) 13.6
Set2 (Drug Data) 19.7
Set2 (Metabolites) 16.6
Set2 (Cost sensitive classification of Drug data) 12.3
Set3(Drug Data) 21.2
Set3 (Metabolites) 15.6
Set3 (Cost sensitive classification of Drug data) 12.1compounds labeled predicted as non- mutagens) and
10774 compounds as True negatives (non-mutagens com-
pounds labeled predicted as non-mutagens) from 12557
compounds. This indicates that 85% of the compounds in
the zinc metabolite dataset are non-mutagenic.
Analysis of false positives and false negatives results
Erroneous compounds i.e. the false positives, false nega-
tives were observed for the test set of Set 3, drug data
sets, and metabolites. Each data set is described below.
Set 3: The test set contained 1698 compounds of which
910 compounds were classified as mutagens and 788 as
non-mutagens. False Negatives (Mutagenic compounds
incorrectly classified as Non-Mutagens) appeared in
the test sets which resulted in 121 compounds. It wasSet 2, Set 3 with random forest
False Negatives True Negative False Positives
83.3 84.6 15.4
82.8 84 16
86.4 90.2 9.8
80.3 84.4 15.6
83.4 85.3 14.7
87.7 91 9
78.8 85.3 14.7
84.4 85.8 14.2
87.9 90.8 9.2
Figure 6 Represents some compounds which are Mutagenic but predicted as Non Mutagen(False Negative) by Random Forest in the
test set.
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being classified as non-mutagens. From 121 false nega-
tives, derivatives of 18 aromatic nitro groups, 9 quinoline,
7 butyl acetate, 5 cresol, 4 phenanthrene, 4 acetanilide, 3
carbinol, 3 methyl aminoethanol, 3 azo compounds were
observed and the remaining were singletons. Some of the
compounds are given in Figure 6. 131 false positives (non
mutagenic compounds incorrectly classified as mutagenic)
compounds were also predicted by the Random Forest
classifier. It was observed that 14 aromatic nitro groups,
21 styrene groups, 4 anisoles, 4 benzylamines, 4 dimethy-
laniline, containing compounds were predicted as muta-
genic due to presence of aromatic nitro group, 3
quinolines. Additional file 4 contains the smiles and the
predicted results of false positives and false negativesFigure 7 Shows false positive compounds of the test sets.of the test set. Figure 7 shows some false positive
compounds.
DrugBank data set: It was observed that 207 compounds
where predicted as mutagens among 1410 approved drugs.
It was found that compounds containing some essential
toxicophores were classified as mutagenic. The structures
present in the Figure 8 are drugs which are predicted as
false positives. For example, Tacrine which was used to
treat Alzheimer’s disease is a centrally active acetyl cholin-
esterase inhibitor but it was also observed that it induces
reversible increase in transaminase activity leading to hep-
atic injury to 30-50% of the patients [34]. Ciprofloxacin a
flourinated quinoline belonging to the class of antibiotics
which includes other drugs such as the enoxacin, fleroxa-
cin, norfloxacin, ofloxacin etc. Ciprofloxacin is associated
Figure 8 Shows some drugs predicted as false positives.
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with cases of renal failure. This drug has been predicted as
false positive which indicates that the model predicted the
compound which was labeled non mutagen is originally
mutagenic.
Of the 66 withdrawn drugs labeled as mutagens, only 14
compounds were identified as mutagens. The drugs were
withdrawn from the market due to signs of toxicity and
adverse effects to humans. Side effects include hepatotox-
icity, hepatitis, teratogenicity (study of human birth
defects), myocardial infarction, mutagenicity and others.
In the withdrawn data 52 compounds were predicted by
Random Forest as non mutagens. Figure 9 shows some of
the compounds which are predicted as false negatives.
Additional file 5 contains smiles and the predicted results
of approved and withdrawn compounds.
Metabolites data set: This data set contained 22080
compounds and around 3269 compounds were pre-
dicted as mutagens. The Additional file 6 contains theFigure 9 Shows the withdrawn drug compounds predicted as false nZINC ids and smiles along with predictions of the Ran-
dom Forest Set 3 classifier.
Comparison of the random forest with CAESAR
The results of the Random Forest classifier were com-
pared with the standalone CAESAR mutagenicity soft-
ware (v.2.0). The results are provided in the Table 8. It
was observed that CAESAR was unable to predict cer-
tain compounds that contained ions in their structure.
For the validation sets AID1194, AID 1189 and the
test sets of Set 3, the total number of predicted
mutagens were 394,788 and 910 respectively. The
non-mutagens predicted to be were 438,697 and 788
for the above sets. The CAESAR tool is based on the
structural alerts described by Ashby, Kazius et al.
[36]. The tool was unable to predict correctly
163,322,124 compounds for AID 1194, AID1189 and
20% of test set respectively in the validated datasets.
The results in the table show number of classifiedegative.
Table 8 Comparison of Caesar with Random Forest (rf)
with the validation sets depicting True Positives (TP),
False Negatives (FN), True Negatives (TN), False Positives
(FP) and Accuracy
TP FN TN FP Accuracy
AID 1194(caesar) 277/394 44/394 289/438 59/438 68.02
AID 1194(rf) 350/395 45/395 400/437 37/437 90.1
AID1189(caesar) 399/788 266/788 334/697 164/697 49.3
AID1189(rf) 436/788 352/788 493/697 204/697 62.9
20%test(caesar) 752/910 113/910 558/788 151/788 77.1
20%test(rf) 789/910 121/910 657/788 131/788 85.15
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pounds in each of the data sets. The comparison clearly
shows that our Random Forest model performed much
better than CAESAR and could even classify compounds
which are not classified by the tool.
Conclusion
Previously the Benchmark data set was the largest muta-
genicity data set containing more than 6000 molecules
classified as mutagens and non-mutagens. In this work
we were able to create a new mutagenicity data set
(Set 3) containing more than 8000 compounds.
The models generated using Random Forest classifier
was observed to have a high performance rate. This
was proved by a higher sensitivity and specificity results
for the validation sets AID1189, AID 1194. Descriptor
optimization is important criteria for model generation,
the use of Gini importance could play an important role
in descriptor space optimization. Other than that the
comparative results of descriptor based Random Forest
with CAESAR (which is based on the structural alerts)
clearly shows that Random Forest has the better predictive
ability to classify mutagenic from non-mutagenic. Classifi-
cation of the Drug data and the metabolite datasets gave
us a clear view the impact of predictive models in drug de-
sign and discovery. The mutagenic predictive models
could make a great impact in classifying compounds in
large repositories such as PubChem and ZINC which
could help to accelerate the pipeline of drug discovery.
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